Aminoglycosides Antibiotics Market

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.
Aminoglycosides Antibiotics Market contains market size and forecasts of Aminoglycosides Antibiotics in global, including the following market information:
Global Aminoglycosides Antibiotics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Aminoglycosides Antibiotics Market Sales, 2017-2022, 2023-2028, (M Units)
Global top five Aminoglycosides Antibiotics companies in 2021 (%)
The global Aminoglycosides Antibiotics market was valued at 1081.9 million in 2021 and is projected to reach US$ 1268.3 million by 2028, at a CAGR of 2.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Neomycin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Aminoglycosides Antibiotics include Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi and Sun Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Aminoglycosides Antibiotics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aminoglycosides Antibiotics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Aminoglycosides Antibiotics Market Segment Percentages, by Type, 2021 (%)
Neomycin
Tobramycin
Gentamicin
Amikacin
Etimicin
Others
Global Aminoglycosides Antibiotics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Aminoglycosides Antibiotics Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Post Care Facility
Government & Military
Others
Global Aminoglycosides Antibiotics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Aminoglycosides Antibiotics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Aminoglycosides Antibiotics revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Aminoglycosides Antibiotics revenues share in global market, 2021 (%)
Key companies Aminoglycosides Antibiotics sales in global market, 2017-2022 (Estimated), (M Units)
Key companies Aminoglycosides Antibiotics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Jemicare
Teva
Novartis
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
Fresenius Kabi
Sun Pharma
Hikma
Lannett Company